ArticlebioRxiv : the preprint server for biology2025

Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2.

Nicolai D Raig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.